SS
ARCT icon

Steve Schonfeld’s Arcturus Therapeutics ARCT Stock Holding History

Steve Schonfeld’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Buy
+26,315
New +$207K ﹤0.01% 2217
2026
Q1 		– Sell
-69,755
Closed -$428K – 2195
2025
Q4 		$428K Sell
69,755
-598,072
-90% -$6.46M ﹤0.01% 1453
2025
Q3 		$12.3M Sell
667,827
-116,580
-15% -$1.87M 0.07% 288
2025
Q2 		$10.2M Sell
784,407
-41,359
-5% -$489K 0.07% 333
2025
Q1 		$8.74M Sell
825,766
-23,315
-3% -$370K 0.05% 365
2024
Q4 		$14.4M Buy
849,081
+479,482
+130% +$9.03M 0.08% 215
2024
Q3 		$8.58M Buy
369,599
+86,179
+30% +$1.84M 0.06% 343
2024
Q2 		$6.9M Sell
283,420
-63,074
-18% -$1.91M 0.04% 466
2024
Q1 		$11.7M Sell
346,494
-54,987
-14% -$1.95M 0.08% 322
2023
Q4 		$12.7M Buy
401,481
+294,325
+275% +$7M 0.08% 280
2023
Q3 		$2.74M Buy
+107,156
New +$3.3M 0.02% 723
2022
Q4 		– Sell
-41,567
Closed -$616K – 2573
2022
Q3 		$616K Sell
41,567
-226,030
-84% -$3.79M 0.01% 1598
2022
Q2 		$4.21M Buy
267,597
+191,501
+252% +$3.76M 0.04% 520
2022
Q1 		$2.05M Buy
76,096
+20,348
+36% +$519K 0.02% 729
2021
Q4 		$2.06M Sell
55,748
-44,879
-45% -$1.83M 0.02% 694
2021
Q3 		$4.81M Buy
100,627
+77,095
+328% +$3.45M 0.05% 450
2021
Q2 		$796K Buy
23,532
+4,324
+23% +$146K 0.01% 1004
2021
Q1 		$793K Sell
19,208
-16,060
-46% -$957K 0.01% 980
2020
Q4 		$1.53M Sell
35,268
-129,102
-79% -$8.74M 0.02% 677
2020
Q3 		$7.05M Buy
164,370
+144,933
+746% +$7.19M 0.13% 214
2020
Q2 		$908K Buy
+19,437
New +$670K 0.02% 621

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Steve Schonfeld's ARCT Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 26,315 shares worth $177K. The stake represents ﹤0.01% of the portfolio and ranks #2217 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ARCT as recently as Q4 2025.

Steve Schonfeld first reported a position in ARCT in Q2 2020 and has held it in 21 quarters since. The position peaked at $14.4M in Q4 2024. 133 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Steve Schonfeld held 26,315 shares of Arcturus Therapeutics worth $177K as of Q2 2026.
  • Arcturus Therapeutics was a new Steve Schonfeld position in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2217 holding.
  • Steve Schonfeld first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 21 quarters since.
  • Steve Schonfeld's Arcturus Therapeutics position peaked at $14.4M in Q4 2024.
  • 133 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.